(629 Kb) Apr 2026

The approval and reimbursement of selpercatinib for RET-positive advanced NSCLC was supported by comparing trial data against RWE from databases like Flatiron Health . 3. Evaluating Quality of Care

The reference (kilobytes) is most commonly associated with a specific scholarly review regarding the use of Real-World Evidence (RWE) in the management of lung cancer, published in the journal Current Oncology . Real-World Evidence in Lung Cancer Management (629 KB)

Patients with comorbidities like COPD or cardiovascular disease are often ineligible for trials, leaving a gap in data regarding how they will respond to new therapies like immune-checkpoint inhibitors. 2. Rare Molecular Subsets Real-World Evidence in Lung Cancer Management Patients with

Real-world evidence refers to clinical evidence derived from the analysis of , which is collected from sources outside of traditional highly-controlled randomized clinical trials (RCTs). These sources include electronic health records, insurance claims, and product/disease registries. 1. Addressing Gaps in Clinical Trials These sources include electronic health records

While the lung cancer article is a primary match for those specific keywords, "629 KB" also appears in these technical and medical contexts: